Sodium fusidate: Phase II started

Cempra began an open-label, U.S. Phase II trial in about 50 patients to compare oral CEM-102 plus rifampin for 6 weeks vs. standard of care consisting of IV antibiotics such as vancomycin, nafcillin o...